Pfizer requests FDA expand authorization to include 12 to 15 year olds
UPDATE 1-Pfizer, BioNTech seek U.S. emergency nod for COVID-19 vaccine in adolescents
European Union Looks To Buy 1.8B Pfizer-BioNTech COVID-19 Vaccine Doses From 2022: Reuters
CORRECTION: White House Vaccination Goal Is 200 Million Shots In 100 Days.
UPDATE: Pfizer-BioNTech Say Requests Based On Data From Pivotal Phase 3 Trial In Adolescents 12 To 15 Years Of Age With Or Without Prior Evidence Of Sars-Cov-2 Infection
Pfizer-BioNTech Request Regulatory Agencies Expand Emergency Use Of Their COVID-19 Vaccine To Adolescents; Ask Agencies To Expand Emergency Use Of Vaccine
BioNTech shares are trading higher after White House COVID-19 Response Coordinator Jeff Zients recently said the US in on track of meeting the goal of 100 million shots in 100 days.
UPDATE: Zients Says Millions Of COVID Vaccine Doses Have Been Distributed But Not Administered As Shots In Arms
WHO Chief Says Must Increase Vaccines Quickly, Or Variants To Gain